Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
02:30:00 03/12/2024 am IST
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.36L 12.51L 11.43L 21.57L 15Cr 21.79L 1.48Cr 57.46L 7.5Cr 58.52L 57.25L 25Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.77Cr -2.6Cr -2.37Cr -4.48Cr -308.68Cr -4.53Cr -31Cr -12Cr -155.74Cr -12Cr -12Cr -515.74Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.02% | 15.59L | |
| -0.27% | +2.14% | +2.32% | +24.42% | 5.17TCr | |
| -0.09% | -2.14% | +492.60% | +537.84% | 4.53TCr | |
| -0.32% | +8.08% | +37.97% | +18.45% | 4.27TCr | |
| +1.18% | +1.96% | +21.95% | +89.69% | 4.28TCr | |
| -2.27% | -3.02% | +14.22% | +51.50% | 3.29TCr | |
| -0.96% | +4.03% | +31.55% | +136.34% | 1.71TCr | |
| +0.41% | +1.66% | - | - | 1.66TCr | |
| -0.03% | +4.61% | +12.79% | +30.51% | 1.5TCr | |
| -0.31% | +6.61% | +81.37% | +48.53% | 1.42TCr | |
| Average | -2.71% | +0.09% | +77.20% | +93.92% | 2.78TCr | |
| Weighted average by Cap. | -0.29% | +2.74% | +104.53% | +135.40% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 12.77L 11.96L 10.93L 20.62L 14Cr 20.83L 1.41Cr 54.94L 7.17Cr 55.95L 54.73L 24Cr | 8L 7L 6L 6L 10.87L 7.48Cr 10.97L 74.35L 28.94L 3.78Cr 29.48L 28.83L 13Cr |
| Net income | -4.42Cr -3.78Cr -3.55Cr -3.24Cr -6.11Cr -421.09Cr -6.17Cr -42Cr -16Cr -212.45Cr -17Cr -16Cr -703.57Cr | -3.95Cr -3.38Cr -3.17Cr -2.9Cr -5.46Cr -376.37Cr -5.52Cr -37Cr -15Cr -189.89Cr -15Cr -15Cr -628.85Cr |
| Net Debt | -6.36Cr -5.45Cr -5.11Cr -4.67Cr -8.81Cr -606.68Cr -8.9Cr -60Cr -23Cr -306.09Cr -24Cr -23Cr -1.01TCr | -3.39Cr -2.91Cr -2.72Cr -2.49Cr -4.7Cr -323.54Cr -4.74Cr -32Cr -13Cr -163.23Cr -13Cr -12Cr -540.57Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
